Abstract
Introduction Using artificial intelligence in imaging practice helps ensure study list reprioritization, prompt attention to urgent studies, and reduces the reporting turn-around time.
Purpose We tested a deep learning-based artificial intelligence model that can detect COVID-19 pneumonia patterns from digital chest radiographs.
Material and Methods The deep learning model was built using the enhanced U-Net architecture with Spatial Attention Gate and Xception Encoder. The model was named DxCOVID and was tested on an external clinical dataset. The dataset included 2247 chest radiographs comprising CXRs from 1046 COVID-19 positive patients (positive on RT-PCR) and 1201 COVID-19 negative patients.
Results We compared the performance of the model with three different radiologists by adjusting the model’s sensitivity as per the individual radiologist. The area under the curve (AUC) on the receiver operating characteristic (ROC) of the model was 0.87 [95% CI: 0.85, 0.89].
Conclusion When compared to the performance of three expert readers, DxCOVID matched the output of two of the three readers. Disease-specific deep learning models using current technology are mature enough to match radiologists’ performance and can be a suitable tool to be incorporated into imaging workflows.
Competing Interest Statement
AK is a Professor at Dr. DY Patil Medical College, Pune, and is also a co-founder of DeepTek Inc., whose expertise was employed to build this model. VD is a Professor of Radiology at Keck School of Medicine, USC, USA, and is also on the advisory board of DeepTek Inc. He is a consultant to Radmetrix Inc, Cohere Inc, and Westat Inc.
Funding Statement
The authors received no financial support for the research, authorship, and/or publication of this article.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Dr DY Patil Medical College, Hospital and Research Center, DY Patil Vidyapeeth, DPU, Pune, India gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos